Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatients

被引:63
作者
List, MA
Rutherford, JL
Stracks, J
Pauloski, BR
Logemann, JA
Lundy, D
Sullivan, P
Goodwin, W
Kies, M
Vokes, EE
机构
[1] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA
[3] Northwestern Univ, Dept Commun Sci & Disorders, Chicago, IL 60611 USA
[4] Univ Miami, Miami, FL 33152 USA
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[7] Univ Chicago, Dept Med, Chicago, IL 60637 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2004年 / 26卷 / 02期
关键词
head and neck cancer; patient priorities; patients versus nonpatients;
D O I
10.1002/hed.10367
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Treatment decisions in head and neck cancer (HNC) might involve consideration of uncertain tradeoffs of one late effect against another or increasing toxicity or residual impairment for increased chance of survival. Understanding how patients prioritize potential outcomes, as well as whether these preferences are similar to those of nonpatients, is important to informed decision making and treatment planning. Methods. Two hundred forty-seven newly diagnosed HNC patients from nine institutions and 131 nonpatients rank ordered a set of 12 potential treatment outcomes (eg, cure, being able to swallow, normal voice) from highest (1) to lowest (12). Results. Patients and nonpatients were similar with respect to the three items most frequently ranked in the top three, that is, "being cured of cancer," "living as long as possible," and "having no pain,'' in that order. In contrast, patients more frequently ranked "cure" (90% vs 80%) and less frequently ranked "no pain" (34% vs 52%) in the top three. Conclusions. Survival seems to be of paramount importance to both patient and nonpatient groups, overshadowing associated toxicities and potential dysfunction. At the same time, patients may be more willing than nonpatients to undergo aggressive treatments and endure acute distress in the interest of potential long-term gains (ie, cure or longer survival). (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 26 条
[1]  
BLANCHARD CG, 1995, J PSYCHOSOC ONCOL, P13
[2]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[3]  
de Graeff A, 1999, HEAD NECK-J SCI SPEC, V21, P291, DOI 10.1002/(SICI)1097-0347(199907)21:4<291::AID-HED1>3.0.CO
[4]  
2-B
[5]   A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy [J].
de Graeff, A ;
de Leeuw, JRJ ;
Ros, WJG ;
Hordijk, GJ ;
Blijham, GH ;
Winnubst, JAM .
ORAL ONCOLOGY, 1999, 35 (01) :27-32
[6]   Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer [J].
de Graeff, A ;
de Leeuw, JRJ ;
Ros, WJG ;
Hordijk, GJ ;
Blijham, GH ;
Winnubst, JAM .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) :332-339
[7]  
Epstein JB, 1999, HEAD NECK-J SCI SPEC, V21, P1
[8]   Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy:: The importance of the target volume [J].
Huguenin, PU ;
Taussky, D ;
Moe, K ;
Meister, A ;
Baumert, B ;
Lütolf, UM ;
Glanzmann, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01) :47-52
[9]   How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? [J].
List, MA ;
Stracks, J ;
Colangelo, L ;
Butler, P ;
Ganzenko, N ;
Lundy, D ;
Sullivan, P ;
Haraf, D ;
Kies, M ;
Goodwin, W ;
Vokes, EE .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :877-884
[10]  
List MA, 1996, CANCER-AM CANCER SOC, V77, P2294, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.3.CO